Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 22-Dec-22 6:53 PM View:  | Arcellx, Inc. (ACLX) | 20-Dec-22 | Acquisition (other) | 30,821 | -- | -- | < 1% 6.75M to 6.78M | |
| 22-Dec-22 6:53 PM View: | Arcellx, Inc. (ACLX) | 20-Dec-22 | Disposition (other) Duplicate | 2,030,000 | -- | -- | (30%) 6.78M to 4.75M | |
| 02-Dec-22 5:12 PM View: | Akouos, Inc. (AKUS) | 30-Nov-22 | Disposition (change in control) Duplicate | 4,294,210 | -- | -- | (100%) 4.29M to 0 | |
| 18-Nov-22 5:14 PM View: | Ionq, Inc. (DMYD=) | 16-Nov-22 | Acquisition (other) | 180,175 | -- | -- | < 1% 26.31M to 26.49M | |
| 18-Nov-22 5:14 PM View: | Ionq, Inc. (DMYD=) | 16-Nov-22 | Disposition (other) Duplicate | 11,867,200 | -- | -- | (45%) 26.49M to 14.62M | |
| 21-Oct-22 4:53 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 19-Oct-22 | Acquisition (other) | 4,013,870 | -- | -- | 102% 3.95M to 7.97M | |
| 21-Oct-22 4:53 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 19-Oct-22 | Disposition (other) Duplicate | 7,965,210 | -- | -- | (100%) 7.97M to 1.62K | |
| 26-May-22 6:31 PM View: | Genocea Biosciences, Inc. (GNCA) | 25-May-22 | Sale Duplicate | 4,445,090 | $0.08 | $362,720.00 | (100%) 4.45M to 0 | |
| 26-May-22 6:31 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-May-22 | Sale Duplicate | 5,931,840 | $0.07 | $387,942.00 | (57%) 10.38M to 4.45M | |
| 04-May-22 7:52 PM View: | Robinhood Markets, Inc. (HOOD) | 02-May-22 | Acquisition (other) | 366,288 | -- | -- | < 1% 47.66M to 48.02M | |
| 04-May-22 7:52 PM View: | Robinhood Markets, Inc. (HOOD) | 02-May-22 | Disposition (other) Duplicate | 24,180,300 | -- | -- | (50%) 48.02M to 23.84M | |
| 13-Apr-22 5:26 PM View: | Trevi Therapeutics, Inc. (TRVI) | 11-Apr-22 | Purchase Duplicate | 3,580,530 | $1.90 | $6,803,000.00 | 46% 7.79M to 11.37M | |
| 01-Feb-22 7:25 PM View: | Robinhood Markets, Inc. (HOOD) | 28-Jan-22 | Acquisition (other) | 366,880 | -- | -- | < 1% 71.51M to 71.88M | |
| 01-Feb-22 7:25 PM View: | Robinhood Markets, Inc. (HOOD) | 28-Jan-22 | Disposition (other) Duplicate | 24,223,700 | -- | -- | (34%) 71.88M to 47.66M | |
| 27-Dec-21 4:46 PM View: | Metacrine, Inc. (MTCR) | 22-Dec-21 | Market Sale Duplicate | 459,700 | $0.97 | $444,853.00 | (15%) 3.02M to 2.56M | 14% |
| 27-Dec-21 4:46 PM View: | Metacrine, Inc. (MTCR) | 10-Dec-21 | Market Sale Duplicate | 37,570 | $1.32 | $49,630.00 | (1%) 3.06M to 3.02M | 37% |
| 12-Nov-21 4:41 PM View: | Robinhood Markets, Inc. (HOOD) | 10-Nov-21 | Acquisition (other) Duplicate | 21,744 | -- | -- | < 1% 72.94M to 72.96M | |
| 12-Nov-21 4:41 PM View: | Robinhood Markets, Inc. (HOOD) | 10-Nov-21 | Disposition (other) Duplicate | 1,449,600 | -- | -- | (2%) 72.96M to 71.51M | |
| 29-Oct-21 5:20 PM View: | Robinhood Markets, Inc. (HOOD) | 27-Oct-21 | Acquisition (other) Duplicate | 21,744 | -- | -- | < 1% 74.37M to 74.39M | |
| 29-Oct-21 5:20 PM View: | Robinhood Markets, Inc. (HOOD) | 27-Oct-21 | Disposition (other) Duplicate | 1,449,600 | -- | -- | (2%) 74.39M to 72.94M | |
| 19-Oct-21 9:15 PM View: | Trevi Therapeutics, Inc. (TRVI) | 18-Oct-21 | Purchase Duplicate | 1,851,850 | -- | -- | 31% 5.94M to 7.79M | |
| 30-Jun-21 6:08 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Conversion Duplicate | 6,642,300 | -- | -- | 100% 0 to 6.64M | |
| 30-Jun-21 6:08 PM View: | Monte Rosa Therapeutics, Inc. (GLUE) | 28-Jun-21 | Purchase Duplicate | 1,050,000 | $19.00 | $19,950,000.00 | 16% 6.64M to 7.69M | |
| 30-Jun-21 9:33 PM View: | Neuehealth, Inc. (NEUE) | 28-Jun-21 | Conversion Duplicate | 133,640,000 | -- | -- | 285% 46.86M to 180.5M | |
| 30-Jun-21 9:33 PM View: | Neuehealth, Inc. (NEUE) | 28-Jun-21 | Market Purchase Duplicate | 1,944,440 | $18.00 | $35,000,000.00 | 1% 180.5M to 182.44M | |
| 10-Jun-21 4:45 PM View: | Desktop Metal, Inc. (DM) | 08-Jun-21 | Acquisition (other) | 138,693 | -- | -- | < 1% 28.26M to 28.4M | |
| 10-Jun-21 4:45 PM View: | Desktop Metal, Inc. (DM) | 08-Jun-21 | Disposition (other) Duplicate | 9,135,000 | -- | -- | (32%) 28.4M to 19.27M | |
| 26-May-21 4:42 PM View: | Eargo, Inc. (EAR) | 24-May-21 | Acquisition (other) | 30,821 | -- | -- | < 1% 6.52M to 6.55M | |
| 26-May-21 4:42 PM View: | Eargo, Inc. (EAR) | 24-May-21 | Disposition (other) Duplicate | 2,030,000 | -- | -- | (31%) 6.55M to 4.52M | |
| 18-Mar-21 5:17 PM View: | Marker Therapeutics, Inc. (MRKR) | 16-Mar-21 | Market Purchase Duplicate | 5,714,280 | $1.75 | $10,000,000.00 | 114% 5.0M to 10.71M | (100%) |
| 07-Dec-20 5:13 PM View: | Regulus Therapeutics Inc. (RGLS) | 04-Dec-20 | Private Purchase Duplicate | 4,398,600 | $0.62 | $2,735,930.00 | 214% 2.05M to 6.45M | |
| 22-Oct-20 7:55 PM View: | Eargo, Inc. (EAR) | 20-Oct-20 | Conversion Duplicate | 6,208,910 | -- | -- | 100% 0 to 6.21M | |
| 22-Oct-20 7:55 PM View: | Eargo, Inc. (EAR) | 20-Oct-20 | Purchase Duplicate | 311,111 | $18.00 | $5,600,000.00 | 5% 6.21M to 6.52M | |
| 22-Sep-20 5:46 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Conversion Duplicate | 2,291,300 | -- | -- | 100% 0 to 2.29M | |
| 22-Sep-20 5:46 PM View: | Metacrine, Inc. (MTCR) | 18-Sep-20 | Purchase Duplicate | 769,230 | $13.00 | $9,999,990.00 | 34% 2.29M to 3.06M | |
| 16-Sep-20 4:48 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Sep-20 | Acquisition (other) | 30,596 | -- | -- | < 1% 7.96M to 7.99M | |
| 16-Sep-20 4:48 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Sep-20 | Acquisition (other) | 248 | -- | -- | < 1% 7.99M to 7.99M | |
| 16-Sep-20 4:48 PM View: | Mersana Therapeutics, Inc. (MRSN) | 14-Sep-20 | Disposition (other) Duplicate | 2,030,000 | -- | -- | (25%) 7.99M to 5.96M | |
| 28-Jul-20 6:30 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Conversion Duplicate | 2,187,690 | -- | -- | 100% 0 to 2.19M | |
| 28-Jul-20 6:30 PM View: | Inozyme Pharma, Inc. (INZY) | 28-Jul-20 | Purchase Duplicate | 250,000 | $16.00 | $4,000,000.00 | 11% 2.19M to 2.44M | |
| 28-Jul-20 5:26 PM View: | Genocea Biosciences, Inc. (GNCA) | 24-Jul-20 | Private Purchase Duplicate | 3,151,260 | $2.25 | $7,090,340.00 | 44% 7.23M to 10.38M | |
| 16-Jul-20 5:00 PM View: | Nkarta, Inc. (NKTX) | 14-Jul-20 | Conversion Duplicate | 2,235,450 | -- | -- | 100% 0 to 2.24M | |
| 16-Jul-20 5:00 PM View: | Nkarta, Inc. (NKTX) | 14-Jul-20 | Purchase Duplicate | 666,666 | $18.00 | $12,000,000.00 | 30% 2.24M to 2.9M | |
| 01-Jul-20 5:57 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Conversion Duplicate | 3,705,970 | -- | -- | 100% 0 to 3.71M | |
| 01-Jul-20 5:57 PM View: | Akouos, Inc. (AKUS) | 30-Jun-20 | Purchase Duplicate | 588,235 | $17.00 | $10,000,000.00 | 16% 3.71M to 4.29M | |
| 22-Jun-20 5:31 PM View: | AVEO Pharmaceuticals, Inc. (AVEO) | 19-Jun-20 | Market Purchase Duplicate | 1,428,570 | $5.25 | $7,500,000.00 | 57% 2.52M to 3.95M | 9% |
| 16-Sep-20 4:48 PM View: | Mersana Therapeutics, Inc. (MRSN) | 06-May-20 | Gift | 1,146 | -- | -- | (< 1%) 7.96M to 7.96M | |
| 13-Apr-20 9:10 PM View: | Mersana Therapeutics, Inc. (MRSN) | 09-Apr-20 | Acquisition (other) | 61,146 | -- | -- | < 1% 11.96M to 12.02M | |
| 13-Apr-20 9:10 PM View: | Mersana Therapeutics, Inc. (MRSN) | 09-Apr-20 | Acquisition (other) | 497 | -- | -- | < 1% 12.02M to 12.02M | |
| 13-Apr-20 9:10 PM View: | Mersana Therapeutics, Inc. (MRSN) | 09-Apr-20 | Disposition (other) Duplicate | 4,060,000 | -- | -- | (34%) 12.02M to 7.96M |